Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Binding of LcrV protein from Yersinia pestis to human T-cells induces apoptosis, which is completely blocked by specific antibodies.

Abramov VM, Kosarev IV, Motin VL, Khlebnikov VS, Vasilenko RN, Sakulin VK, Machulin AV, Uversky VN, Karlyshev AV.

Int J Biol Macromol. 2019 Feb 1;122:1062-1070. doi: 10.1016/j.ijbiomac.2018.09.054. Epub 2018 Sep 12.

PMID:
30218736
2.

Humoral and cellular immune responses to Yersinia pestis Pla antigen in humans immunized with live plague vaccine.

Feodorova VA, Lyapina AM, Khizhnyakova MA, Zaitsev SS, Sayapina LV, Arseneva TE, Trukhachev AL, Lebedeva SA, Telepnev MV, Ulianova OV, Lyapina EP, Ulyanov SS, Motin VL.

PLoS Negl Trop Dis. 2018 Jun 11;12(6):e0006511. doi: 10.1371/journal.pntd.0006511. eCollection 2018 Jun.

3.

Phylogeny and Classification of Yersinia pestis Through the Lens of Strains From the Plague Foci of Commonwealth of Independent States.

Kutyrev VV, Eroshenko GA, Motin VL, Nosov NY, Krasnov JM, Kukleva LM, Nikiforov KA, Al'khova ZV, Oglodin EG, Guseva NP.

Front Microbiol. 2018 May 25;9:1106. doi: 10.3389/fmicb.2018.01106. eCollection 2018.

4.

Urogenital Chlamydia trachomatis multilocus sequence types and genovar distribution in chlamydia infected patients in a multi-ethnic region of Saratov, Russia.

Feodorova VA, Konnova SS, Saltykov YV, Zaitsev SS, Subbotina IA, Polyanina TI, Ulyanov SS, Lamers SL, Gaydos CA, Quinn TC, Motin VL.

PLoS One. 2018 Apr 11;13(4):e0195386. doi: 10.1371/journal.pone.0195386. eCollection 2018.

5.

New Insights into Autoinducer-2 Signaling as a Virulence Regulator in a Mouse Model of Pneumonic Plague.

Fitts EC, Andersson JA, Kirtley ML, Sha J, Erova TE, Chauhan S, Motin VL, Chopra AK.

mSphere. 2016 Dec 14;1(6). pii: e00342-16. eCollection 2016 Nov-Dec.

6.

Two Isoforms of Yersinia pestis Plasminogen Activator Pla: Intraspecies Distribution, Intrinsic Disorder Propensity, and Contribution to Virulence.

Dentovskaya SV, Platonov ME, Svetoch TE, Kopylov PK, Kombarova TI, Ivanov SA, Shaikhutdinova RZ, Kolombet LV, Chauhan S, Ablamunits VG, Motin VL, Uversky VN, Anisimov AP.

PLoS One. 2016 Dec 9;11(12):e0168089. doi: 10.1371/journal.pone.0168089. eCollection 2016.

7.

Yersinia pestis in the Age of Big Data.

Yang R, Motin VL.

Adv Exp Med Biol. 2016;918:257-272. Review.

PMID:
27722866
8.

A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.

Sha J, Kirtley ML, Klages C, Erova TE, Telepnev M, Ponnusamy D, Fitts EC, Baze WB, Sivasubramani SK, Lawrence WS, Patrikeev I, Peel JE, Andersson JA, Kozlova EV, Tiner BL, Peterson JW, McWilliams D, Patel S, Rothe E, Motin VL, Chopra AK.

Clin Vaccine Immunol. 2016 Jul 5;23(7):586-600. doi: 10.1128/CVI.00150-16. Print 2016 Jul.

9.

Assessment of Live Plague Vaccine Candidates.

Feodorova VA, Sayapina LV, Motin VL.

Methods Mol Biol. 2016;1403:487-98. doi: 10.1007/978-1-4939-3387-7_27.

PMID:
27076149
10.

New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria.

Andersson JA, Fitts EC, Kirtley ML, Ponnusamy D, Peniche AG, Dann SM, Motin VL, Chauhan S, Rosenzweig JA, Sha J, Chopra AK.

Antimicrob Agents Chemother. 2016 May 23;60(6):3717-29. doi: 10.1128/AAC.00326-16. Print 2016 Jun.

11.

Expression and Association of the Yersinia pestis Translocon Proteins, YopB and YopD, Are Facilitated by Nanolipoprotein Particles.

Coleman MA, Cappuccio JA, Blanchette CD, Gao T, Arroyo ES, Hinz AK, Bourguet FA, Segelke B, Hoeprich PD, Huser T, Laurence TA, Motin VL, Chromy BA.

PLoS One. 2016 Mar 25;11(3):e0150166. doi: 10.1371/journal.pone.0150166. eCollection 2016.

12.

Polymorphism of the Cysteine Protease YopT from Yersinia pestis.

Platonov ME, Svetoch TE, Evseeva VV, Knyazeva AI, Dentovskaya SV, Motin VL, Uversky VN, Anisimov AP.

Protein Pept Lett. 2016;23(4):379-85.

PMID:
26845766
13.

CRP-Mediated Carbon Catabolite Regulation of Yersinia pestis Biofilm Formation Is Enhanced by the Carbon Storage Regulator Protein, CsrA.

Willias SP, Chauhan S, Lo CC, Chain PS, Motin VL.

PLoS One. 2015 Aug 25;10(8):e0135481. doi: 10.1371/journal.pone.0135481. eCollection 2015.

14.

Russian vaccines against especially dangerous bacterial pathogens.

Feodorova VA, Sayapina LV, Corbel MJ, Motin VL.

Emerg Microbes Infect. 2014 Dec;3(12):e86. doi: 10.1038/emi.2014.82. Epub 2014 Dec 17. Review.

15.

Further characterization of a highly attenuated Yersinia pestis CO92 mutant deleted for the genes encoding Braun lipoprotein and plasminogen activator protease in murine alveolar and primary human macrophages.

van Lier CJ, Tiner BL, Chauhan S, Motin VL, Fitts EC, Huante MB, Endsley JJ, Ponnusamy D, Sha J, Chopra AK.

Microb Pathog. 2015 Mar;80:27-38. doi: 10.1016/j.micpath.2015.02.005. Epub 2015 Feb 16.

16.

Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague.

Tiner BL, Sha J, Kirtley ML, Erova TE, Popov VL, Baze WB, van Lier CJ, Ponnusamy D, Andersson JA, Motin VL, Chauhan S, Chopra AK.

Infect Immun. 2015 Apr;83(4):1318-38. doi: 10.1128/IAI.02778-14. Epub 2015 Jan 20.

17.

Functional characterization of Yersinia pestis aerobic glycerol metabolism.

Willias SP, Chauhan S, Motin VL.

Microb Pathog. 2014 Nov;76:33-43. doi: 10.1016/j.micpath.2014.08.010. Epub 2014 Sep 16.

18.

Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine.

Erova TE, Rosenzweig JA, Sha J, Suarez G, Sierra JC, Kirtley ML, van Lier CJ, Telepnev MV, Motin VL, Chopra AK.

Clin Vaccine Immunol. 2013 Feb;20(2):227-38. doi: 10.1128/CVI.00597-12. Epub 2012 Dec 12.

19.

A multi-omic systems approach to elucidating Yersinia virulence mechanisms.

Ansong C, Schrimpe-Rutledge AC, Mitchell HD, Chauhan S, Jones MB, Kim YM, McAteer K, Deatherage Kaiser BL, Dubois JL, Brewer HM, Frank BC, McDermott JE, Metz TO, Peterson SN, Smith RD, Motin VL, Adkins JN.

Mol Biosyst. 2013 Jan 27;9(1):44-54. doi: 10.1039/c2mb25287b. Epub 2012 Nov 13.

20.

Plague vaccines: current developments and future perspectives.

Feodorova VA, Motin VL.

Emerg Microbes Infect. 2012 Nov;1(11):e36. doi: 10.1038/emi.2012.34. Epub 2012 Nov 7. Review.

21.

Comparative omics-driven genome annotation refinement: application across Yersiniae.

Schrimpe-Rutledge AC, Jones MB, Chauhan S, Purvine SO, Sanford JA, Monroe ME, Brewer HM, Payne SH, Ansong C, Frank BC, Smith RD, Peterson SN, Motin VL, Adkins JN.

PLoS One. 2012;7(3):e33903. doi: 10.1371/journal.pone.0033903. Epub 2012 Mar 27. Erratum in: PLoS One. 2012;7(8). doi: 10.1371/annotation/03110e8b-3e10-4334-9ff7-969c85ad25d8.

22.

An experimentally-supported genome-scale metabolic network reconstruction for Yersinia pestis CO92.

Charusanti P, Chauhan S, McAteer K, Lerman JA, Hyduke DR, Motin VL, Ansong C, Adkins JN, Palsson BO.

BMC Syst Biol. 2011 Oct 13;5:163. doi: 10.1186/1752-0509-5-163.

23.

Characterization of an F1 deletion mutant of Yersinia pestis CO92, pathogenic role of F1 antigen in bubonic and pneumonic plague, and evaluation of sensitivity and specificity of F1 antigen capture-based dipsticks.

Sha J, Endsley JJ, Kirtley ML, Foltz SM, Huante MB, Erova TE, Kozlova EV, Popov VL, Yeager LA, Zudina IV, Motin VL, Peterson JW, DeBord KL, Chopra AK.

J Clin Microbiol. 2011 May;49(5):1708-15. doi: 10.1128/JCM.00064-11. Epub 2011 Mar 2.

24.

Improved detection of Bartonella DNA in mammalian hosts and arthropod vectors by real-time PCR using the NADH dehydrogenase gamma subunit (nuoG).

Colborn JM, Kosoy MY, Motin VL, Telepnev MV, Valbuena G, Myint KS, Fofanov Y, Putonti C, Feng C, Peruski L.

J Clin Microbiol. 2010 Dec;48(12):4630-3. doi: 10.1128/JCM.00470-10. Epub 2010 Oct 6.

25.

Tetraacylated lipopolysaccharide of Yersinia pestis can inhibit multiple Toll-like receptor-mediated signaling pathways in human dendritic cells.

Telepnev MV, Klimpel GR, Haithcoat J, Knirel YA, Anisimov AP, Motin VL.

J Infect Dis. 2009 Dec 1;200(11):1694-702. doi: 10.1086/647986. Erratum in: J Infect Dis. 2010 Jan 15;201(2):314.

PMID:
19863438
26.

Amino acid and structural variability of Yersinia pestis LcrV protein.

Anisimov AP, Dentovskaya SV, Panfertsev EA, Svetoch TE, Kopylov PKh, Segelke BW, Zemla A, Telepnev MV, Motin VL.

Infect Genet Evol. 2010 Jan;10(1):137-45. doi: 10.1016/j.meegid.2009.10.003. Epub 2009 Oct 14.

27.

Evaluation of a Yersinia pestis mutant impaired in a thermoregulated type VI-like secretion system in flea, macrophage and murine models.

Robinson JB, Telepnev MV, Zudina IV, Bouyer D, Montenieri JA, Bearden SW, Gage KL, Agar SL, Foltz SM, Chauhan S, Chopra AK, Motin VL.

Microb Pathog. 2009 Nov;47(5):243-51. doi: 10.1016/j.micpath.2009.08.005. Epub 2009 Aug 27.

28.

Comparative antimicrobial activity of granulysin against bacterial biothreat agents.

Endsley JJ, Torres AG, Gonzales CM, Kosykh VG, Motin VL, Peterson JW, Estes DM, Klimpel GR.

Open Microbiol J. 2009 Jun 5;3:92-6. doi: 10.2174/1874285800903010092.

29.

Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens.

Feodorova VA, Pan'kina LN, Savostina EP, Kuznetsov OS, Konnov NP, Sayapina LV, Dentovskaya SV, Shaikhutdinova RZ, Ageev SA, Lindner B, Kondakova AN, Bystrova OV, Kocharova NA, Senchenkova SN, Holst O, Pier GB, Knirel YA, Anisimov AP, Motin VL.

Vaccine. 2009 Apr 6;27(16):2240-50. doi: 10.1016/j.vaccine.2009.02.020. Epub 2009 Feb 13.

30.

Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague.

Sha J, Agar SL, Baze WB, Olano JP, Fadl AA, Erova TE, Wang S, Foltz SM, Suarez G, Motin VL, Chauhan S, Klimpel GR, Peterson JW, Chopra AK.

Infect Immun. 2008 Apr;76(4):1390-409. doi: 10.1128/IAI.01529-07. Epub 2008 Jan 28.

31.

Molecular characterization of L-413C, a P2-related plague diagnostic bacteriophage.

Garcia E, Chain P, Elliott JM, Bobrov AG, Motin VL, Kirillina O, Lao V, Calendar R, Filippov AA.

Virology. 2008 Mar 1;372(1):85-96. Epub 2007 Nov 28.

32.

Substrate specificity and screening of the integral membrane protease Pla.

Agarkov A, Chauhan S, Lory PJ, Gilbertson SR, Motin VL.

Bioorg Med Chem Lett. 2008 Jan 1;18(1):427-31. Epub 2007 Oct 12.

33.

Direct transcriptional control of the plasminogen activator gene of Yersinia pestis by the cyclic AMP receptor protein.

Kim TJ, Chauhan S, Motin VL, Goh EB, Igo MM, Young GM.

J Bacteriol. 2007 Dec;189(24):8890-900. Epub 2007 Oct 12.

34.

A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs.

Feodorova VA, Pan'kina LN, Savostina EP, Sayapina LV, Motin VL, Dentovskaya SV, Shaikhutdinova RZ, Ivanov SA, Lindner B, Kondakova AN, Bystrova OV, Kocharova NA, Senchenkova SN, Holst O, Pier GB, Knirel YA, Anisimov AP.

Vaccine. 2007 Nov 1;25(44):7620-8. Epub 2007 Sep 14.

PMID:
17913308
35.

Attachment of LcrV from Yersinia pestis at dual binding sites to human TLR-2 and human IFN-gamma receptor.

Abramov VM, Khlebnikov VS, Vasiliev AM, Kosarev IV, Vasilenko RN, Kulikova NL, Khodyakova AV, Evstigneev VI, Uversky VN, Motin VL, Smirnov GB, Brubaker RR.

J Proteome Res. 2007 Jun;6(6):2222-31. Epub 2007 Apr 19.

PMID:
17441749
36.

Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis.

Chain PS, Carniel E, Larimer FW, Lamerdin J, Stoutland PO, Regala WM, Georgescu AM, Vergez LM, Land ML, Motin VL, Brubaker RR, Fowler J, Hinnebusch J, Marceau M, Medigue C, Simonet M, Chenal-Francisque V, Souza B, Dacheux D, Elliott JM, Derbise A, Hauser LJ, Garcia E.

Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13826-31. Epub 2004 Sep 9.

37.

Temporal global changes in gene expression during temperature transition in Yersinia pestis.

Motin VL, Georgescu AM, Fitch JP, Gu PP, Nelson DO, Mabery SL, Garnham JB, Sokhansanj BA, Ott LL, Coleman MA, Elliott JM, Kegelmeyer LM, Wyrobek AJ, Slezak TR, Brubaker RR, Garcia E.

J Bacteriol. 2004 Sep;186(18):6298-305.

38.

Genetic variability of Yersinia pestis isolates as predicted by PCR-based IS100 genotyping and analysis of structural genes encoding glycerol-3-phosphate dehydrogenase (glpD).

Motin VL, Georgescu AM, Elliott JM, Hu P, Worsham PL, Ott LL, Slezak TR, Sokhansanj BA, Regala WM, Brubaker RR, Garcia E.

J Bacteriol. 2002 Feb;184(4):1019-27.

39.

Detection and identification of virulence factors in Yersinia pestis using SELDI ProteinChip system.

Thulasiraman V, McCutchen-Maloney SL, Motin VL, Garcia E.

Biotechniques. 2001 Feb;30(2):428-32.

40.

Molecular characterization of KatY (antigen 5), a thermoregulated chromosomally encoded catalase-peroxidase of Yersinia pestis.

Garcia E, Nedialkov YA, Elliott J, Motin VL, Brubaker RR.

J Bacteriol. 1999 May;181(10):3114-22.

42.

Expression of the plague plasminogen activator in Yersinia pseudotuberculosis and Escherichia coli.

Kutyrev V, Mehigh RJ, Motin VL, Pokrovskaya MS, Smirnov GB, Brubaker RR.

Infect Immun. 1999 Mar;67(3):1359-67.

43.
44.

Suppression of mouse skin allograft rejection by protein A-Yersiniae V antigen fusion peptide.

Motin VL, Kutas SM, Brubaker RR.

Transplantation. 1997 Apr 15;63(7):1040-2.

PMID:
9112365
46.

V antigen-polyhistidine fusion peptide: binding to LcrH and active immunity against plague.

Motin VL, Nedialkov YA, Brubaker RR.

Infect Immun. 1996 Oct;64(10):4313-8.

47.
48.

Sequencing of two Yersinia pestis IS elements, IS285 and IS100.

Filippov AA, Oleinikov PV, Motin VL, Protsenko OA, Smirnov GB.

Contrib Microbiol Immunol. 1995;13:306-9. No abstract available.

PMID:
8833859
49.

Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide.

Motin VL, Nakajima R, Smirnov GB, Brubaker RR.

Infect Immun. 1994 Oct;62(10):4192-201.

50.

Identification of Rickettsia prowazekii using the polymerase chain reaction.

Aniskovich LP, Motin VL, Lichoded LJ, Balayeva NM, Smirnov GB.

Eur J Epidemiol. 1993 Nov;9(6):645-9.

PMID:
8150068

Supplemental Content

Loading ...
Support Center